Vanguard Fiduciary Trust
KRRO icon

Vanguard Fiduciary Trust’s Korro Bio KRRO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$987K Buy
74,901
+33,360
+80% +$414K ﹤0.01% 3026
2026
Q1 		$470K Buy
+41,541
New +$457K ﹤0.01% 3231

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Fiduciary Trust's KRRO Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Korro Bio (KRRO) stake by 80% in Q2 2026, buying an estimated $414K and bringing the position to 74,901 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #3026.

Vanguard Fiduciary Trust first reported a position in KRRO in Q1 2026 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Vanguard Fiduciary Trust held 74,901 shares of Korro Bio worth $987K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 33,360 Korro Bio shares in Q2 2026, an estimated $414K.
  • Korro Bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3026 holding.
  • Vanguard Fiduciary Trust first reported a position in Korro Bio in Q1 2026 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.